Zydus Wellness Limited (BOM:531335)
India · Delayed Price · Currency is INR 414.55
-1.50 (-0.36%)
At close: Feb 11, 2026
Zydus Wellness Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 3,469 | 2,669 | 3,104 | 3,089 | 1,187 |
Depreciation & Amortization | 276 | 207 | 210 | 193.6 | 216.7 |
Other Amortization | 8 | 31 | 40 | 42.6 | 34.9 |
Loss (Gain) From Sale of Assets | 4 | -35 | 1 | 0.3 | -3 |
Loss (Gain) From Sale of Investments | -98 | -25 | -16 | -11.1 | -21.8 |
Provision & Write-off of Bad Debts | 3 | 10 | - | 12.3 | 6.3 |
Other Operating Activities | 406 | 45 | -23 | 105.3 | 2,103 |
Change in Accounts Receivable | -653 | -761 | -650 | -528.3 | 221.7 |
Change in Inventory | -398 | -101 | -958 | 30.8 | -723.8 |
Change in Accounts Payable | 513 | 485 | -530 | -699.3 | -426 |
Change in Other Net Operating Assets | 270 | -61 | -261 | 133.6 | 272.2 |
Operating Cash Flow | 3,800 | 2,464 | 917 | 2,369 | 2,867 |
Operating Cash Flow Growth | 54.22% | 168.70% | -61.28% | -17.40% | 10.60% |
Capital Expenditures | -663 | -285 | -450 | -754.4 | -196.6 |
Sale of Property, Plant & Equipment | 10 | 21 | 6 | 7.1 | 22 |
Cash Acquisitions | -3,690 | - | - | - | - |
Divestitures | 2 | - | - | - | - |
Investment in Securities | 547 | -47 | -413 | -205.1 | 2.9 |
Other Investing Activities | 1,557 | -1,474 | 32 | 92.9 | 67.6 |
Investing Cash Flow | -2,236 | -1,777 | -849 | -859.5 | -104.1 |
Short-Term Debt Issued | - | 940 | 1,610 | 192.5 | 2,182 |
Long-Term Debt Issued | - | - | - | - | 3,125 |
Total Debt Issued | - | 940 | 1,610 | 192.5 | 5,307 |
Short-Term Debt Repaid | -1,390 | - | - | - | - |
Long-Term Debt Repaid | -19 | -643 | -2,517 | -1,887 | -15,002 |
Total Debt Repaid | -1,409 | -643 | -2,517 | -1,887 | -15,002 |
Net Debt Issued (Repaid) | -1,409 | 297 | -907 | -1,695 | -9,695 |
Issuance of Common Stock | - | - | - | - | 9,866 |
Common Dividends Paid | -318 | -319 | -319 | -318.8 | -1.9 |
Other Financing Activities | -136 | -235 | -159 | -324.9 | -2,333 |
Financing Cash Flow | -1,863 | -257 | -1,385 | -2,338 | -2,164 |
Miscellaneous Cash Flow Adjustments | 166 | - | - | - | - |
Net Cash Flow | -133 | 430 | -1,317 | -829.2 | 598.9 |
Free Cash Flow | 3,137 | 2,179 | 467 | 1,614 | 2,671 |
Free Cash Flow Growth | 43.96% | 366.60% | -71.07% | -39.56% | 13.83% |
Free Cash Flow Margin | 11.58% | 9.36% | 2.07% | 8.03% | 14.31% |
Free Cash Flow Per Share | 9.86 | 6.85 | 1.47 | 5.07 | 8.79 |
Cash Interest Paid | 136 | 235 | 159 | 324.9 | 1,012 |
Cash Income Tax Paid | -29 | 27 | 13 | 41.1 | -2 |
Levered Free Cash Flow | 2,279 | 703.75 | -661.13 | 242.81 | 793.95 |
Unlevered Free Cash Flow | 2,352 | 851.88 | -562.38 | 399.75 | 1,315 |
Change in Working Capital | -268 | -438 | -2,399 | -1,063 | -655.9 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.